Company Celltrion Healthcare Co., Ltd.
Equities
A091990
KR7091990002
Pharmaceuticals
Business Summary
Number of employees: 120
Sales per Business
KRW in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
98.9
%
| 1,783,637 | 98.6 % | 1,950,503 | 98.9 % | +9.36% |
Other
1.0
%
| 17,794 | 1.0 % | 19,520 | 1.0 % | +9.70% |
Service Provision
0.1
%
| 7,008 | 0.4 % | 2,165 | 0.1 % | -69.11% |
Sales per region
KRW in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
39.8
%
| 726,201 | 40.2 % | 785,912 | 39.8 % | +8.22% |
Europe
35.8
%
| 782,074 | 43.3 % | 705,571 | 35.8 % | -9.78% |
Asia
14.0
%
| 200,024 | 11.1 % | 275,578 | 14.0 % | +37.77% |
South America and Others
10.0
%
| 94,551 | 5.2 % | 197,686 | 10.0 % | +109.08% |
South Korea
0.4
%
| 1,636 | 0.1 % | 7,441 | 0.4 % | +354.83% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 62 | - |
Jung Kim
CMP | Compliance Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Han
BRD | Director/Board Member | 68 | 16-03-28 |
Jung-Jin Seo
CHM | Chairman | 66 | - |
Wu-Sung Ki
CEO | Chief Executive Officer | 62 | - |
Eung-Yeol Choe
BRD | Director/Board Member | 66 | 18-03-28 |
Un-Gab Jeong
BRD | Director/Board Member | 57 | 18-03-28 |
Hyeon-Ju Ra
BRD | Director/Board Member | 59 | 18-05-28 |
Han-Gi Lee
BRD | Director/Board Member | 47 | 10-12-31 |
Joong-Jae Lee
BRD | Director/Board Member | 61 | - |
Jun-Seok Seo
CHM | Chairman | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 164,464,724 | 97,611,660 ( 59.35 %) | 5,141,351 ( 3.126 %) | 59.35 % |
Company contact information
Celltrion Healthcare Co., Ltd.
19, Academy-ro 51beon-gil Yeonsu-gu
22014, Inchon
+82 3 2850 6400
http://www.celltrionhealthcare.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-5.32% | 84.57B | |
+2.11% | 39.93B | |
-25.74% | 27.93B | |
+51.96% | 24.21B | |
-6.17% | 17.17B | |
-31.09% | 13.93B | |
-6.58% | 12.3B | |
-16.04% | 11.84B | |
-4.19% | 7.91B |